SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CoTherix (CTRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (8)3/22/2005 3:40:09 PM
From: tuck  Read Replies (1) of 18
 
RE: IPF data. Ain't none, which rkrw surely knew. Pilot study to be launched this year; I'd guess about three months long. Given that enrollment won't be instant, but numbers will be small, so it shouldn't be too slow . . . data no earlier than second half for sure, and probably late 2nd half at that. Since we're talking about PH as secondary to IPF (current approval is for patients with cardiac conditions), wouldn't these patients be part of the 50,000 market size?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News